ArticleThe American journal of pathology2021

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors.

Tobias Furlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.